Positive Allosteric Modulation of Antithrombin's Inhibitory Activity by RNA Aptamers
Nucleic Acid Therapeutics · 2023
DOI: 10.1089/nat.2022.0047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, 2023. Verfasst von Khalequz Zaman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biology Department, Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Aptamers, Nucleotide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biology Department, Case Western Reserve University, Cleveland, Ohio, USA.
ORCID-Profile: Yolanda M Fortenberry
Zitieren
APA
Zaman, K., Breitman, A., Malik, I., & Fortenberry, Y. M. (2023). Positive Allosteric Modulation of Antithrombin's Inhibitory Activity by RNA Aptamers. Nucleic Acid Therapeutics. https://doi.org/10.1089/nat.2022.0047
Vancouver
Zaman K, Breitman A, Malik I, Fortenberry YM. Positive Allosteric Modulation of Antithrombin's Inhibitory Activity by RNA Aptamers. Nucleic Acid Therapeutics. 2023. doi:10.1089/nat.2022.0047
BibTeX
@article{Zaman2023,
author = {Zaman, Khalequz and Breitman, Adi and Malik, Isa and Fortenberry, Yolanda M},
title = {Positive Allosteric Modulation of Antithrombin's Inhibitory Activity by RNA Aptamers},
journal = {Nucleic Acid Therapeutics},
year = {2023},
doi = {10.1089/nat.2022.0047}
}
EUVIMED